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Introduction
Patients with atrial fibrillation (AF) often suffer from
blood clots originating from the left atrial appendage
(LAA). As these clots are the main cause of central and
peripheral embolism, patients receive oral anticoagula-
tion therapy. For those patients who cannot be treated
effectively with oral anticoagulants, percutaneous trans-
catheter LAA occlusion systems have been invented as a
promising alternative.
Purpose
To test the feasibility of cardiac magnetic resonance
imaging (CMR) for device size selection and for moni-
toring LAA occlusion in AF patients.
Methods
Patients scheduled for LAA occlusion received CMR
before and after device deployment. Left atrial angiogra-
phy, and 3D navigator and delayed enhancement
sequences were applied. The size of the left atrium (LA),
LAA, and position and size of the occluder were
measured.
Results
10 patients (7 male, age 71±10 years) received a LAA
occluder system (Amplatzer, AGA Medical Corp,
Golden Valley/ MN, USA). 4/10 patients suffered from
paroxymal, 6/10 from permanent AF, 6/10 from hyper-
tension, and 4/10 from coronary artery disease with 2
having a prior myocardial infarction. 9/10 had a history
of at least one stroke, 1/10 of TIA. CMR (Siemens
Espree 1.5T, Germany) showed an ejection fraction of
58.3±5.2%, LA diameter of 58.1±17.2mm, and LAA
diameter of 25.7±4.5mm before device implantation.
Manufacturing occluder diameters were 25.1±4.7mm,
resulting in a difference of 1.6±0.3mm as compared to
measured LAA. After a follow-up period of 24±4 weeks,
there was no device dislocation or thrombotic formation
detected by CMR. LA diameter was 54.1±7.6 mm,
LAA diameter 27.9±3.2mm, and occluder diameter
25.3±4.9mm. 9/10 occluders were leakproof, 1/10 was a
little untight, showing a small contrast agent rim around
the occluder. Figure 1 shows an CMR example after
LAA occluder implantation (Ao=aorta, RA=right atrium,
RV=right ventricle, full arrow=LAA occluder).
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Conclusion
CMR allows visualization of LAA and selection of the
optimal LAA occluder size. CMR is feasible in patients
after LAA occluder implantation, and seems to be safe
for evaluation of device position, size, and tightness.
Therefore, CMR seems to be a valuable visualization
tool for LAA occluder implantation, and should be rou-
tinely used for long-term monitoring of device deploy-
ment success.
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